FDA approves drug to fight high cholesterol

By  | 

The U.S. Food and Drug Administration has approved a new cholesterol-lowering medication.

Esperion's Nexletol is a once-daily tablet which is an alternative for millions of patients that cannot take, or don't respond well, to statins.

The company says it's the first oral non-statin drug approved in nearly two decades.

During studies, the drug reduced cholesterol in patients by an average of 18% when used with moderate or high intensity statins.

Nexletol could become available as early as late March.



 
Comments are posted from viewers like you and do not always reflect the views of this station. powered by Disqus